Brooklyn Investment Group Buys Shares of 2,835 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Brooklyn Investment Group bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,835 shares of the medical instruments supplier’s stock, valued at approximately $77,000.

A number of other hedge funds also recently added to or reduced their stakes in XRAY. First Eagle Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after purchasing an additional 3,283,965 shares during the last quarter. Nuance Investments LLC grew its stake in shares of DENTSPLY SIRONA by 3.8% during the second quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after acquiring an additional 402,329 shares in the last quarter. FMR LLC grew its stake in DENTSPLY SIRONA by 5.1% in the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after purchasing an additional 436,031 shares in the last quarter. Cooke & Bieler LP grew its stake in DENTSPLY SIRONA by 16.2% in the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after purchasing an additional 1,046,105 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after purchasing an additional 1,308,411 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

XRAY opened at $19.64 on Friday. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business’s 50 day moving average is $22.83 and its 200-day moving average is $24.89.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same quarter last year, the business earned $0.49 earnings per share. The business’s revenue for the quarter was up .4% on a year-over-year basis. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

Analyst Ratings Changes

XRAY has been the subject of a number of research reports. Barrington Research decreased their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Evercore ISI decreased their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Needham & Company LLC cut their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $29.50.

View Our Latest Stock Analysis on XRAY

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.